S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Richard I. Fisher, MD
James P. Wilmot Cancer Center
Study Chair - Steven H. Bernstein, MD
James P. Wilmot Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
147 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alaska Regional Hospital Cancer Center
Anchorage, Alaska, United States
- Providence Cancer Center
Anchorage, Alaska, United States
- Arizona Cancer Center at University of Arizona Health Sciences Center
Tucson, Arizona, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Providence Saint Joseph Medical Center - Burbank
Burbank, California, United States
- North Bay Cancer Center
Fairfield, California, United States
- Poudre Valley Hospital
Fort Collins, Colorado, United States
- Broward General Medical Center Cancer Center
Fort Lauderdale, Florida, United States
- M.D. Anderson Cancer Center at Orlando
Orlando, Florida, United States
- Mountain States Tumor Institute at St. Luke'S Regional Medical Center
Boise, Idaho, United States
- Decatur Memorial Hospital Cancer Care Institute
Decatur, Illinois, United States
- St. Francis Hospital and Health Centers - Beech Grove Campus
Beech Grove, Indiana, United States
- Reid Hospital & Health Care Services
Richmond, Indiana, United States
- Cancer Center of Kansas, Pa - Chanute
Chanute, Kansas, United States
- Cancer Center of Kansas, Pa - Dodge City
Dodge City, Kansas, United States
- Cancer Center of Kansas, Pa - El Dorado
El Dorado, Kansas, United States
- Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas, United States
- Cancer Center of Kansas, Pa - Kingman
Kingman, Kansas, United States
- Southwest Medical Center
Liberal, Kansas, United States
- Cancer Center of Kansas, Pa - Newton
Newton, Kansas, United States
- Olathe Cancer Center
Olathe, Kansas, United States
- Cancer Center of Kansas, Pa - Parsons
Parsons, Kansas, United States
- Cancer Center of Kansas, Pa - Pratt
Pratt, Kansas, United States
- Cancer Center of Kansas, Pa - Salina
Salina, Kansas, United States
- Tammy Walker Cancer Center at Salina Regional Health Center
Salina, Kansas, United States
- Cotton-O'Neil Cancer Center
Topeka, Kansas, United States
- St. Francis Comprehensive Cancer Center
Topeka, Kansas, United States
- Cancer Center of Kansas, Pa - Wellington
Wellington, Kansas, United States
- Associates in Womens Health, Pa - North Review
Wichita, Kansas, United States
- Ccop - Wichita
Wichita, Kansas, United States
- Cancer Center of Kansas, Pa - Medical Arts Tower
Wichita, Kansas, United States
- Cancer Center of Kansas, Pa - Wichita
Wichita, Kansas, United States
- Via Christi Cancer Center at Via Christi Regional Medical Center
Wichita, Kansas, United States
- Cancer Center of Kansas, Pa - Winfield
Winfield, Kansas, United States
- Boston University Cancer Research Center
Boston, Massachusetts, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Battle Creek Health System Cancer Care Center
Battle Creek, Michigan, United States
- Mecosta County Medical Center
Big Rapids, Michigan, United States
- Butterworth Hospital at Spectrum Health
Grand Rapids, Michigan, United States
- Ccop - Grand Rapids
Grand Rapids, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2006
- Primary completion
- 31 Dec 2012
- Completion
- 30 Sept 2017
- Last update posted
- 6 Nov 2017
- Registered enrollment
- 68
- Registry id
- NCT00376961
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.